• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

[Neurology] Heavy alcohol intake and intracerebral hemorrhage: Characteristics and effect on outcome

bys25qthea
September 12, 2012
in Chronic Disease, Neurology, Surgery
Reading Time: 3 mins read
Share on FacebookShare on Twitter

Image:CC/Silktork

Primer: Heavy alcohol consumption has long been considered a risk factor for intracranial hemorrhage (ICH), yet there exists little research regarding the effect of excessive alcohol intake on the characteristics and outcomes of spontaneous ICH. The authors of this article conducted a large prospective cohort study to answer two important questions:

  • How do ICH characteristics differ in those with heavy alcohol consumption compared to those without?
  • How does alcohol intake influence short and long term outcomes in patients who suffer spontaneous ICH?

This [prospective cohort] study: Over 5 years, demographic, clinical, and radiologic data as well alcohol intake and medical histories were collected for 540 patients admitted to the Lille University Hospital for acute stroke with CT evidence of parenchymal hemorrhage. Of these, 137 were classified as heavy alcohol drinkers (current and regular consumption of more than 300 g of alcohol per week). Statistical analysis comparing heavy drinkers to non-heavy drinkers revealed a few key findings:

  • Heavy drinkers presented with ICH at a younger median age of 60 years (IQR: 52-69) versus non-heavy drinkers who presented at median age 74 years (IQR: 62-81) (p < 0.0001).
  • In heavy drinkers, platelet count (205 million/L) and prothrombin ratio (92%) were significantly lower in compared to their non-heavy drinker counterparts (platelet ct. = 222 billion/L; prothrombin ratio = 86%).
  • Patients with heavy alcohol intake were more likely to suffer a non-lobar (deep or posterior fossa) ICH (OR 1.71, CI: 1.05-2.77).
  • Heavy drinkers did not experience any increase in intrahospital complications or length of hospital stay. However, in patients less than 60 years of age who suffered a non-lobar ICH, mortality was higher in those with heavy alcohol intake (HR 1.96, CI: 1.06-3.63).

In sum: This study found that among patients presenting with intracranial hemorrhage (ICH), those who consume large amounts of alcohol were more likely to be younger in age. Higher rates of ICH in non-lobar locations and increased incidence of low platelet count and low prothrombin ratio in heavy drinkers suggest that both small-vessel disease and hemostatic disorders may play a role in ICH manifestation. Finally, alcohol consumption was only predictive of mortality in a small subset of study subjects – those who were young (less than 60 years of age) and who suffered a non-lobar ICH. The authors of the study note that while these results show “alcohol has an impact on vital outcome among young patients with ICH… it remains a risk factor and not a cause itself.”

Click to read in Neurology

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCALIMER: Posts are not medical advice and are not intended as such. Please aee a healthcare professional if you seek medical advice.

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

FDA-cleared AI devices rarely have patient outcome data

Previous Post

[NATURE] Neonatal RSV infection associated with increased susceptibility to allergic asthma

Next Post

[CIRCULATION] NSAID use after heart attacks associated with increased coronary risk, death

RelatedReports

Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Endocrinology

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

September 10, 2026
Public Health

FDA-cleared AI devices rarely have patient outcome data

September 10, 2026
Nephrology

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

September 9, 2026
Next Post

[CIRCULATION] NSAID use after heart attacks associated with increased coronary risk, death

[Ann Intern Med.] Asymptomatic, low risk women should not be screened for ovarian cancer – new USPSTF statement

[JAMA] Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Chronic exposure to particulate matter is associated with increased cardiovascular risk
  • Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans
  • FDA-cleared AI devices rarely have patient outcome data
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.